Airway Management Devices Market

Executive Summary

Airway Management Devices Market was valued at US $1.71 billion in 2021 and is projected to grow at 6.64% CAGR over the forecast period to reach US $2.51 billion by 2027. Airway Management Devices Market represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.80 billion opportunity in 2027 over 2021.

Airway Management Devices from Consainsights analyses the Airway Management Devices Market in the Life Sciences industry over the forecast period to 2027.

Airway Management Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Airway Management Devices segmentation includes Type, Patient Age, Application, End-user, Region and Geography.

Based on the Type, the Airway Management Devices analysis covers Infraglottic Airway Devices, Supraglottic Airway Devices, Laryngoscopes, Resuscitators, Cricothyrotomy Kits, Other Airway Management Devices.

In Type segment, Infraglottic Airway Devices segment has highest cagr growth of 5.88%.

Based on the Patient Age, the Airway Management Devices analysis covers Adult Patients, Pediatric Patients/Neonates.

In Patient Age segment, Adult Patients segment has highest cagr growth of 5.88%.

Based on the Application, the Airway Management Devices analysis covers Anesthesia, Emergency Medicine, Other Applications.

In Application segment, Anesthesia segment has highest cagr growth of 5.88%.

Based on the End-user, the Airway Management Devices analysis covers Hospitals, Ambulatory Care Settings, Home Care Settings, Other End-users.

In End-user segment, Hospitals segment has highest cagr growth of 5.88%.

Based on the Region, the Airway Management Devices analysis covers North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

In Region segment, North America segment has highest cagr growth of 5.88%.

Based on the region, the Airway Management Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Key Players, Other Players and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Infraglottic Airway Devices segment has the highest revenue of US $0.76 billion and is expected to grow at CAGR of 5.88% by 2027 Infraglottic Airway Devices segment has highest cagr growth of 5.88%.

Infraglottic Airway Devices

Infraglottic Airway Devices segment was valued at US $0.67 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $1.11 billion by 2027. Infraglottic Airway Devices segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.36 billion opportunity in 2027 over 2021.

Supraglottic Airway Devices

Supraglottic Airway Devices segment was valued at US $0.39 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.65 billion by 2027. Supraglottic Airway Devices segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.

Laryngoscopes

Laryngoscopes segment was valued at US $0.23 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.38 billion by 2027. Laryngoscopes segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.12 billion opportunity in 2027 over 2021.

Resuscitators

Resuscitators segment was valued at US $0.10 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.18 billion by 2027. Resuscitators segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.06 billion opportunity in 2027 over 2021.

Cricothyrotomy Kits

Cricothyrotomy Kits segment was valued at US $0.06 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.11 billion by 2027. Cricothyrotomy Kits segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

Other Airway Management Devices

Other Airway Management Devices segment was valued at US $0.05 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.09 billion by 2027. Other Airway Management Devices segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

Patient Age

Introduction

In 2021, Adult Patients segment has the highest revenue of US $1.12 billion and is expected to grow at CAGR of 5.88% by 2027 Adult Patients segment has highest cagr growth of 5.88%.

Adult Patients

Adult Patients segment was valued at US $0.98 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $1.64 billion by 2027. Adult Patients segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.52 billion opportunity in 2027 over 2021.

Pediatric Patients/Neonates

Pediatric Patients/Neonates segment was valued at US $0.52 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.87 billion by 2027. Pediatric Patients/Neonates segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.28 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Anesthesia segment has the highest revenue of US $0.91 billion and is expected to grow at CAGR of 5.88% by 2027 Anesthesia segment has highest cagr growth of 5.88%.

Anesthesia

Anesthesia segment was valued at US $0.80 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $1.33 billion by 2027. Anesthesia segment represented US $0.11 billion opportunity over 2019-2021 and estimated to create US $0.43 billion opportunity in 2027 over 2021.

Emergency Medicine

Emergency Medicine segment was valued at US $0.55 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.92 billion by 2027. Emergency Medicine segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.15 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.26 billion by 2027. Other Applications segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.

End-user

Introduction

In 2021, Hospitals segment has the highest revenue of US $0.68 billion and is expected to grow at CAGR of 5.88% by 2027 Hospitals segment has highest cagr growth of 5.88%.

Hospitals

Hospitals segment was valued at US $0.60 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $1.00 billion by 2027. Hospitals segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.32 billion opportunity in 2027 over 2021.

Ambulatory Care Settings

Ambulatory Care Settings segment was valued at US $0.42 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.70 billion by 2027. Ambulatory Care Settings segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.22 billion opportunity in 2027 over 2021.

Home Care Settings

Home Care Settings segment was valued at US $0.31 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.52 billion by 2027. Home Care Settings segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Other End-users

Other End-users segment was valued at US $0.18 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.29 billion by 2027. Other End-users segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $0.75 billion and is expected to grow at CAGR of 5.88% by 2027 North America segment has highest cagr growth of 5.88%.

North America

North America segment was valued at US $0.66 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $1.11 billion by 2027. North America segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.35 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.38 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.63 billion by 2027. Europe segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.20 billion opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $0.18 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.31 billion by 2027. Asia-Pacific segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.

Latin America

Latin America segment was valued at US $0.21 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.35 billion by 2027. Latin America segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.11 billion opportunity in 2027 over 2021.

Middle East and Africa

Middle East and Africa segment was valued at US $0.06 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $0.11 billion by 2027. Middle East and Africa segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.